MedPath

GlaxoSmithKline

GlaxoSmithKline logo
🇬🇧United Kingdom
Ownership
Public
Established
1929-01-01
Employees
70.2K
Market Cap
$90B
Website
http://www.gsk.com
Introduction

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward

Phase 1
Completed
Conditions
Substance Dependence
Interventions
First Posted Date
2008-01-31
Last Posted Date
2017-07-21
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
29
Registration Number
NCT00605241
Locations
🇺🇸

GSK Investigational Site, Philadelphia, Pennsylvania, United States

Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects

Phase 1
Completed
Conditions
Rhinitis, Allergic, Seasonal
Interventions
Drug: Placebo
First Posted Date
2008-01-31
Last Posted Date
2017-08-21
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
29
Registration Number
NCT00605852
Locations
🇬🇧

GSK Investigational Site, London, United Kingdom

Bioequivalence and Food Effect of 250mg of Lamotrigine XR

Phase 1
Completed
Conditions
Epilepsy
Interventions
First Posted Date
2008-01-31
Last Posted Date
2017-09-11
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
209
Registration Number
NCT00605371
Locations
🇺🇸

GSK Investigational Site, Tacoma, Washington, United States

SD Cystic Fibrosis Study

Phase 1
Completed
Conditions
Cystic Fibrosis
Interventions
First Posted Date
2008-01-31
Last Posted Date
2012-03-19
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
9
Registration Number
NCT00605761
Locations
🇺🇸

GSK Investigational Site, Pittsburgh, Pennsylvania, United States

A Drug Interaction Study Between Simvastatin and GSK376501

Phase 1
Completed
Conditions
Type 2 Diabetes Mellitus
First Posted Date
2008-01-31
Last Posted Date
2010-10-19
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
39
Registration Number
NCT00605449
Locations
🇺🇸

GSK Investigational Site, Austin, Texas, United States

Treatment Of Hot Flashes/Flushes In Postmenopausal Women (WARM Study)

Phase 2
Completed
Conditions
Menopausal and Female Climacteric States
Interventions
First Posted Date
2008-01-30
Last Posted Date
2017-10-03
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
356
Registration Number
NCT00604825
Locations
🇬🇧

GSK Investigational Site, Waterloo, Liverpool, United Kingdom

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.

Phase 2
Completed
Conditions
Asthma
Interventions
Drug: Placebo
First Posted Date
2008-01-29
Last Posted Date
2018-04-18
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
599
Registration Number
NCT00603382
Locations
🇸🇪

GSK Investigational Site, Luleå, Sweden

Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy

Phase 3
Terminated
Conditions
Arthritis, Rheumatoid
Interventions
Drug: Placebo
First Posted Date
2008-01-29
Last Posted Date
2014-06-09
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
169
Registration Number
NCT00603525
Locations
🇬🇧

GSK Investigational Site, Leytonstone, London, United Kingdom

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.

Phase 2
Completed
Conditions
Asthma
Interventions
Drug: placebo
First Posted Date
2008-01-29
Last Posted Date
2016-12-28
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
622
Registration Number
NCT00603278
Locations
🇿🇦

GSK Investigational Site, Mowbray, South Africa

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.

Phase 2
Completed
Conditions
Asthma
Interventions
First Posted Date
2008-01-29
Last Posted Date
2017-09-15
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
627
Registration Number
NCT00603746
Locations
🇹🇭

GSK Investigational Site, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath